Category: Cosmetics

Cosmetics in 2026: Critical EU & UK Regulatory Changes Every Brand Must Prepare For
Regulators in the EU and UK are introducing significant cosmetic regulatory updates that will directly impact ingredient selection, labeling, safety assessments, and product claims. Many brands are underestimating the scope — and the timeline. Expanded fragrance allergen disclosures will require label updates. New CMR classifications may trigger reformulation. Silicone and nano ingredient changes could affect
Read more »
2026 Cosmetics Europe Annual Conference
Booth #: Pending
Read more »
2026 NY Suppliers’ Day
Booth #: 2181
Read more »
2026 Natural Products Expo West
Booth #: 209
Read more »
2026 Cosmoprof Bologna

Cosmetics Labeling Requirements Across Major Markets
Expanding into global markets brings exciting opportunities—but it also introduces complex labeling challenges. This session provides a clear, side-by-side comparison of labeling requirements in the United States, Canada, the European Union, and the United Kingdom, helping brands prevent costly mistakes and streamline packaging across regions. Attendees will learn the essential rules that govern cosmetic and
Read more »
1223/2009 Made Practical: The EU–UK Compliance Playbook
Join us for an in-depth webinar that unpacks the essential requirements of Cosmetic Regulation (EC) No. 1223/2009, the cornerstone of cosmetic product safety and compliance in the European Union. Designed for manufacturers, brand owners, and regulatory professionals, this session provides a clear, step-by-step explanation of the regulation’s key provisions and how to achieve and maintain
Read more »
EU Enforcement on IFRA 51: Deadlines, Dossiers, Do’s
Fragrance and flavor ingredients are central to cosmetics and personal care products, but they’re also highly regulated due to their complexity and potential allergens. With the 51st Amendment to the International Fragrance Association (IFRA) Standards going into effect on October 30, 2025, the time to act is now. This significant update introduces new ingredient restrictions,
Read more »
2026 Cosmoprof Miami
Booth #: 606
Read more »
Health Canada Cosmetics Update 2025: What’s Changed and How to Prepare
Canada’s cosmetics regulations are undergoing major changes in 2025, and companies that sell into the Canadian market need to adapt quickly to remain compliant. From new labeling requirements to fragrance allergen disclosures and enhanced safety protocols, Health Canada’s updated rules will impact how products are formulated, packaged, and marketed. In this webinar, our regulatory expert
Read more »
2025 Sunscreen Symposium
Booth Number: 113
Read more »
Don’t Become EU Non-Compliant—Understanding the 51st Amendment of IFRA Standards Enforcement on October 30, 2025
Fragrance and flavor ingredients are central to cosmetics and personal care products, but they’re also highly regulated due to their complexity and potential allergens. With the 51st Amendment to the International Fragrance Association (IFRA) Standards going into effect on October 30, 2025, the time to act is now. This significant update introduces new ingredient restrictions, clarifications, and compliance changes.
Read more »
2025 Global Trade Educational Conference (G-TEC)
Booth Number: Pending
Read more »
Build Better Cosmetics Faster with Cosmetri: The Ultimate Software Solution for Brand Managers
Join us for a webinar introducing Cosmetri for Brand Managers, the innovative software platform with a focus on the specific needs of brand managers in the beauty and personal care industry. Learn how this all-in-one software will streamline your product development process, manage regulatory compliance, and speed up your product launches. We will focus
Read more »
Adapting to Change: Navigating FDA Regulatory Shifts and Evolving Tariff Policies in 2025
As global trade dynamics continue to shift, customs brokers, international suppliers to the U.S., and importers must stay ahead of critical regulatory and policy changes that directly impact compliance and operations. From the evolving enforcement priorities at the U.S. Food and Drug Administration (FDA) to renewed scrutiny of de minimis thresholds and tariff policy under
Read more »







